USD 7.82 billion
Report ID:
SQMIG35D2046 |
Region:
Global |
Published Date: June, 2024
Pages:
157
|Tables:
98
|Figures:
76
Global Next Generation Sequencing Market size was valued at USD 7.82 Billion in 2022 and is poised to grow from USD 9.27 Billion in 2023 to USD 36.04 Billion by 2031, growing at a CAGR of 18.5% in the forecast period (2024-2031).
Next generation sequencing is a technique that employs massive parallelism in sequencing millions or even billions of DNA strands. This method is also known as high throughput sequencing. NGS is less dependent on fragment-cloning strategies that are used in Sanger genome sequencing. The advantages of NGS over Sanger’s sequencing method include low cost, high accuracy and speed, precise results even if small amounts of samples are used. Thus, NGS is widely used in biomarker discovery, cancer studies, personalized medicine, agriculture and animal studies, etc.
Genome sequencing has also been applied to understanding how Covid-19 spreads and can inform how interventions affect disease progression and subsequent treatments. The Covid-19 Genomics U.K. Consortium (COG-U.K.) was set up in March 2020, to utilize Whole-Genome Sequencing to investigate the coronavirus genome. Partners in the cooperation are the Welcome Sanger Institute, the NHS, Public Health Agencies, and other academic institutions. These organizations have collaborated on mapping the virus’s evolution and spread.
US Next Generation Sequencing Market is poised to grow at a sustainable CAGR for the next forecast year.
Global Market Size
USD 7.82 billion
Largest Segment
Instruments
Fastest Growth
Instruments
Growth Rate
18.5% CAGR
To get more reports on the above market click here to Buy The Report
The next generation sequencing market is segmented into Product and Service, Technology, Application, End User and region. Based on the Product & Service, the market is segmented into NGS Consumables, Sequencing Services (Exome & Targeted Resequencing and Custom Panels, RNA Sequencing, DE NOVO Sequencing, Chip Sequencing, Whole-genome sequencing, MethYl Sequencing, Other Sequencing Services), Pre-sequencing Products & Services (Library Preparation And Target Enrichment, Quality Control), NGS Platforms (Illumina [NovaSeq Systems, Nextseq Systems, Miseq Systems, iSeq 100 Systems, Miniseq Systems], Thermo Fisher Scientific, Oxford Nanopore Technologies, Pacific Biosciences, Other NGS Platforms), Bioinformatics (NGS Data Analysis Services, NGS Data Analysis Software and Workbenches, NGS Storage, Management, And Cloud Computing Solutions), Services for NGS Platforms. Based on the Technology, the market is segmented into Sequencing by Synthesis, Ion Semiconductor Sequencing, Nanopore Sequencing, Single-molecule Real-time Sequencing, and Other Sequencing Technologies. Based on Application, the market is segmented into Diagnostics (Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Other Diagnostic Applications, Drug Discovery And Development (Pharmacogenomics, Other Drug Discovery And Development Applications), Agricultural And Animal Research, Other Applications. Based on the End-user, the market is segmented into Academic Institutes And Research Centers, Pharmaceutical And Biotechnology Companies, Hospitals And Clinics, Reference Laboratories, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia-Pacific, South America, and Middle East and Africa.
Analysis by Technology
Sequencing by synthesis is the leading segment in the NGS market since they are highly accurate, easily scalable and relatively affordable. SBS technology is the most common method for platforms like Illumina’s sequencing systems. SBS is used for different purposes and is considered the best method for whole genome sequencing, exome sequencing, and RNA sequencing. It has further increased its dominance through constant innovation and application in clinical and research realms which has led to increased market share.
The nanopore sequencing segment is expected to grow at the highest CAGR in the NGS market. These features include real-time sequencing, longer read length and portability, which makes this technology highly adaptable to various applications including field samples and even point of care. Such companies as Oxford Nanopore Technologies are currently active in this segment and are constantly developing and improving the technology.
Analysis by End-User
Academic institutes and research centers represent the dominant segment in the next-generation sequencing (NGS) market. They are some of the biggest NGS consumers for research, genomics, and large population sequencing projects. In particular, the increased governmental funding for academic research projects as well as the team-based nature of scientific work leads to high demand for NGS platforms. This segment relies on government aid and institutional funding, and therefore constitutes the largest share of the market regarding its revenue and usage.
The pharmaceutical and biotechnology industry is considered the most dynamic segment of the NGS market. The use of Next Generation Sequencing in drug discovery, development and new therapies including personalized medicine is on the rise due to the need for specificity in the development of related therapeutic intervention. These companies use it for biomarker identification, companion diagnostic tests and clinical research, which is helping in the growth of this segment. Due to the functionality of NGS to reduce the time for the development of new drugs and treatments, along with investments in biotechnology, this segment is poised to grow at the highest rate in the foreseeable future.
To get detailed analysis on other segments, Request For Free Sample Report
North America is anticipated to dominate this market in 2023 with its highest market share among other regions. The main driving force for the regional market is the presence of various next generation sequencing players and clinical laboratories that utilize next generation sequencing to perform genetic testing in the region. Apart from this, the introduction of new products by key players and technological improvements in the currently available products will also benefit the regional industry in the forecast period.
In addition, Asia-Pacific is expected to have a market share in the communications software market during the forecast period respectively. The growth of the market in the region can be attributed to the various key players operating in the region for offering services like digital PCR solutions, and next-generation sequencing like BGI Genomics, NGS service providers are – First BASE Laboratories Sdn Bhd, Macrogen Asia-Pacific Pte Ltd. and more. These main players have a broad portfolio that can satisfy almost every need of the consumer. Therefore, this plays a role in the growth of the market in the regional context in the anticipated forecast period.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Next Generation Sequencing Market Driver
Technological Innovations in Sequencing Platforms
Rising Demand for Personalized Medicine
Restraints
High Cost of NGS Technology
Data Management and Interpretation Challenges
Request Free Customization of this report to help us to meet your business objectives.
The market is fragmented in nature. The prominent players operating in the market are always adopting various growth strategies to stay afloat in the market. Product launches, innovations, mergers & acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. The key market players are also constantly focused on R&D to supply industries with the most efficient and cost-effective solutions.
Next Generation Sequencing Market Top Player's Company Profiles
Next Generation Sequencing Market Recent Developments
In December 2023, marked the official release of TurBOT beta access with Oxford Nanopore collaborating with Tecan. The buyers are expected to receive the products by first quarter of the year 2024. The potential of the TurBOT is the availability of basecalling, data analysis, sample preparation as well as automated extraction of multiple samples in a single instrument.
In December 2023, Illumina inked an MoU with African Society for Laboratory Medicine with the aims of deploy genomics in the region of Africa to combat infectious diseases.
In April 2024, in LAUSANNE, Switzerland – NewBiologix technology innovation company, focused on addressing the issues in gene therapy production, has released its new platform for NGS and optical mapping. This integrated set of services is expected to offer the biopharmaceutical industry a convenient and efficient solution for genomic analyses.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. SQ identified the key dominating segments of the market by offerings and verticals.
Based on our study, out of the segment of sequencing, WGS is expected to exhibit a high market dominance rate soon. Out of all the types of products, the reagents and consumables are expected to dominate the market for the given time frame. However, within the end-user spectrum, the academic institutes and research center segment is expected to show the strongest market dominance in the GNGS industry throughout the forecast period.
Report Metric | Details |
---|---|
Market size value in 2022 | USD 7.82 Billion |
Market size value in 2031 | USD 36.04 Billion |
Growth Rate | 18.5% |
Base year | 2023 |
Forecast period | 2024-2031 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Next Generation Sequencing Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Next Generation Sequencing Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Next Generation Sequencing Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Next Generation Sequencing Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35D2046